{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:05:59Z","timestamp":1769126759270,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40256-021-00500-x","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T10:06:31Z","timestamp":1638957991000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study"],"prefix":"10.1007","volume":"22","clinical-trial-number":[{"clinical-trial-number":"isrctn11703380","registry":"10.18810\/isrctn"}],"author":[{"given":"Zhou","family":"Jingmin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Yuhui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Wenhui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"Baopeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Caizhen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Huiyuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9360-7332","authenticated-orcid":false,"given":"Ge","family":"Junbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The POSITIVE investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohai","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luosha","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoming","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baopeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kejun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caizhen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuemin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanglang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruili","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaofen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxia","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guosheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guidong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuangang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"500_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/BF00235525","volume":"70","author":"M Bohm","year":"1992","unstructured":"Bohm M, La Rosee K, Schmidt U, Schulz C, Schwinger RH, Erdmann E. Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure. Clin Investig. 1992;70:421\u20135. https:\/\/doi.org\/10.1007\/BF00235525.","journal-title":"Clin Investig"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2013.07.027","volume":"62","author":"JC Reil","year":"2013","unstructured":"Reil JC, Tardif JC, Ford I, Lloyd SM, O\u2019Meara E, Komajda M, et al. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. J Am Coll Cardiol. 2013;62:1977\u201385. https:\/\/doi.org\/10.1016\/j.jacc.2013.07.027.","journal-title":"J Am Coll Cardiol"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1161\/01.res.41.5.648","volume":"41","author":"RJ Bache","year":"1977","unstructured":"Bache RJ, Cobb FR. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res. 1977;41:648\u201353. https:\/\/doi.org\/10.1161\/01.res.41.5.648.","journal-title":"Circ Res"},{"key":"500_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/ajplegacy.1956.185.2.355","volume":"185","author":"D Laurent","year":"1956","unstructured":"Laurent D, Bolene-Williams C, Williams FL, Katz LN. Effects of heart rate on coronary flow and cardiac oxygen consumption. Am J Physiol. 1956;185:355\u201364. https:\/\/doi.org\/10.1152\/ajplegacy.1956.185.2.355.","journal-title":"Am J Physiol"},{"key":"500_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1253\/circj.cj-10-0925","volume":"75","author":"G Heusch","year":"2011","unstructured":"Heusch G. Heart rate and heart failure. Not a simple relationship. Circ J. 2011;75:229\u201336. https:\/\/doi.org\/10.1253\/circj.cj-10-0925.","journal-title":"Circ J"},{"key":"500_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.001626","author":"WK Laskey","year":"2015","unstructured":"Laskey WK, Alomari I, Cox M, Schulte PJ, Zhao X, Hernandez AF, et al. Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization. J Am Heart Assoc. 2015. https:\/\/doi.org\/10.1161\/jaha.114.001626.","journal-title":"J Am Heart Assoc"},{"key":"500_CR7","first-page":"485","volume":"33","author":"D Logeart","year":"2012","unstructured":"Logeart D, Seronde MF. Raised heart rate at discharge after acute heart failure is an independent predictor of one-year mortality. Eur Heart J. 2012;33:485.","journal-title":"Eur Heart J"},{"key":"500_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s0140-6736(10)61259-7","volume":"376","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet. 2010;376:886\u201394. https:\/\/doi.org\/10.1016\/s0140-6736(10)61259-7.","journal-title":"Lancet"},{"key":"500_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891\u2013975. https:\/\/doi.org\/10.1002\/ejhf.592.","journal-title":"Eur J Heart Fail"},{"key":"500_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70:776\u2013803. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.025.","journal-title":"J Am Coll Cardiol"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"CW Yancy","year":"2016","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, et al. 2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476\u201388. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.011.","journal-title":"J Am Coll Cardiol"},{"key":"500_CR12","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8776","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-327. https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8776.","journal-title":"Circulation"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875\u201385. https:\/\/doi.org\/10.1016\/s0140-6736(10)61198-1.","journal-title":"Lancet"},{"key":"500_CR14","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","volume":"32","author":"JC Tardif","year":"2011","unstructured":"Tardif JC, O\u2019Meara E, Komajda M, Bohm M, Borer JS, Ford I, et al. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J. 2011;32:2507\u201315. https:\/\/doi.org\/10.1093\/eurheartj\/ehr311.","journal-title":"Eur Heart J"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12325-014-0147-3","volume":"31","author":"C Zugck","year":"2014","unstructured":"Zugck C, Martinka P, St\u00f6ckl G. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice. Adv Ther. 2014;31:961\u201374. https:\/\/doi.org\/10.1007\/s12325-014-0147-3.","journal-title":"Adv Ther"},{"key":"500_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ijcard.2017.03.131","volume":"240","author":"C Zugck","year":"2017","unstructured":"Zugck C, St\u00f6rk S, St\u00f6ckl G. Long-term treatment with ivabradine over 12 months in patients with chronic heart failure in clinical practice: effect on symptoms, quality of life and hospitalizations. Int J Cardiol. 2017;240:258\u201364. https:\/\/doi.org\/10.1016\/j.ijcard.2017.03.131.","journal-title":"Int J Cardiol"},{"key":"500_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ijcard.2017.08.001","volume":"249","author":"D Zachariah","year":"2017","unstructured":"Zachariah D, Stevens D, Sidorowicz G, Spooner C, Rowell N, Taylor J, et al. Quality of life improvement in older patients with heart failure initiated on ivabradine: results from the UK multi-centre LIVE:LIFE prospective cohort study. Int J Cardiol. 2017;249:313\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.001.","journal-title":"Int J Cardiol"},{"key":"500_CR18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245\u201355. https:\/\/doi.org\/10.1016\/s0735-1097(00)00531-3.","journal-title":"J Am Coll Cardiol"},{"key":"500_CR19","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","volume":"76","author":"JA Spertus","year":"2020","unstructured":"Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:2379\u201390. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.542.","journal-title":"J Am Coll Cardiol"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3760\/cma.j.issn.0253-3758.2017.03.005","volume":"45","author":"DY Hu","year":"2017","unstructured":"Hu DY, Huang DJ, Yuan ZY, Zhao RP, Yan XW, Wang MH. Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45:190\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2017.03.005.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"500_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijcard.2017.12.093","volume":"260","author":"YM Lopatin","year":"2018","unstructured":"Lopatin YM, Cowie MR, Grebennikova AA, Sisakian HS, Pagava ZM, Hayrapetyan HG, et al. Optimization of heart rate lowering therapy in hospitalized patients with heart failure: insights from the Optimize Heart Failure Care Program. Int J Cardiol. 2018;260:113\u20137. https:\/\/doi.org\/10.1016\/j.ijcard.2017.12.093.","journal-title":"Int J Cardiol"},{"key":"500_CR22","doi-asserted-by":"publisher","unstructured":"Chinese guidelines for the diagnosis and treatment of heart failure 2018 [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46:760-89. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2018.10.004","DOI":"10.3760\/cma.j.issn.0253-3758.2018.10.004"},{"key":"500_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.cardfail.2009.05.003","volume":"15","author":"DK Moser","year":"2009","unstructured":"Moser DK, Yamokoski L, Sun JL, Conway GA, Hartman KA, Graziano JA, et al. Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure. J Card Fail. 2009;15:763\u20139. https:\/\/doi.org\/10.1016\/j.cardfail.2009.05.003.","journal-title":"J Card Fail"},{"key":"500_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.cardfail.2005.03.007","volume":"11","author":"I Ekman","year":"2005","unstructured":"Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA. Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail. 2005;11:288\u201392. https:\/\/doi.org\/10.1016\/j.cardfail.2005.03.007.","journal-title":"J Card Fail"},{"key":"500_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10741-016-9581-4","volume":"22","author":"CM Alpert","year":"2017","unstructured":"Alpert CM, Smith MA, Hummel SL, Hummel EK. Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev. 2017;22:25\u201339. https:\/\/doi.org\/10.1007\/s10741-016-9581-4.","journal-title":"Heart Fail Rev"},{"key":"500_CR26","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","volume":"32","author":"I Ekman","year":"2011","unstructured":"Ekman I, Chassany O, Komajda M, Bohm M, Borer JS, Ford I, et al. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J. 2011;32:2395\u2013404. https:\/\/doi.org\/10.1093\/eurheartj\/ehr343.","journal-title":"Eur Heart J"},{"key":"500_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14740\/cr958","volume":"11","author":"TR Koroma","year":"2020","unstructured":"Koroma TR, Samura SK, Cheng Y, Tang M. Effect of ivabradine on left ventricular diastolic function, exercise tolerance and quality of life in patients with heart failure: a systemic review and meta-analysis of randomized controlled trials. Cardiol Res. 2020;11:40\u20139. https:\/\/doi.org\/10.14740\/cr958.","journal-title":"Cardiol Res"},{"key":"500_CR28","doi-asserted-by":"publisher","first-page":"H676","DOI":"10.1152\/ajpheart.00564.2002","volume":"284","author":"P Colin","year":"2003","unstructured":"Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli JF, et al. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol. 2003;284:H676\u201382. https:\/\/doi.org\/10.1152\/ajpheart.00564.2002.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"500_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ejheart.2008.04.005","volume":"10","author":"GM De Ferrari","year":"2008","unstructured":"De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, et al. Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail. 2008;10:550\u20135. https:\/\/doi.org\/10.1016\/j.ejheart.2008.04.005.","journal-title":"Eur J Heart Fail"},{"key":"500_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2165\/00126839-200304020-00001","volume":"4","author":"AJ Camm","year":"2003","unstructured":"Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D. 2003;4:83\u20139. https:\/\/doi.org\/10.2165\/00126839-200304020-00001.","journal-title":"Drugs R D."},{"key":"500_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000073933","volume":"100","author":"M Manz","year":"2003","unstructured":"Manz M, Reuter M, Lauck G, Omran H, Jung W. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100:149\u201355. https:\/\/doi.org\/10.1159\/000073933.","journal-title":"Cardiology"},{"key":"500_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ejhf.1630","volume":"22","author":"L Li","year":"2020","unstructured":"Li L, Liu R, Jiang C, Du X, Huffman MD, Lam CSP, et al. Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics. Eur J Heart Fail. 2020;22:646\u201360. https:\/\/doi.org\/10.1002\/ejhf.1630.","journal-title":"Eur J Heart Fail"},{"key":"500_CR33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012884","volume":"8","author":"Y Yu","year":"2019","unstructured":"Yu Y, Gupta A, Wu C, Masoudi FA, Du X, Zhang J, et al. Characteristics, management, and outcomes of patients hospitalized for heart failure in China: the China PEACE Retrospective Heart Failure Study. J Am Heart Assoc. 2019;8: e012884. https:\/\/doi.org\/10.1161\/JAHA.119.012884.","journal-title":"J Am Heart Assoc"},{"key":"500_CR34","doi-asserted-by":"publisher","first-page":"M40","DOI":"10.1093\/eurheartj\/suz212","volume":"21","author":"PM Seferovic","year":"2019","unstructured":"Seferovic PM, Polovina MM, Coats AJS. Heart failure in dilated non-ischaemic cardiomyopathy. Eur Heart J Suppl. 2019;21:M40\u20133. https:\/\/doi.org\/10.1093\/eurheartj\/suz212.","journal-title":"Eur Heart J Suppl."},{"key":"500_CR35","doi-asserted-by":"publisher","first-page":"e004112","DOI":"10.1161\/CIRCHEARTFAILURE.117.004112","volume":"10","author":"D Das","year":"2017","unstructured":"Das D, Savarese G, Dahlstrom U, Fu M, Howlett J, Ezekowitz JA, et al. Ivabradine in heart failure: the representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a broad population of patients with chronic heart failure. Circ Heart Fail. 2017;10:e004112. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004112.","journal-title":"Circ Heart Fail"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-021-00500-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-021-00500-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-021-00500-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T13:24:48Z","timestamp":1651584288000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-021-00500-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,8]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1007\/s40256-021-00500-x","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,8]]},"assertion":[{"value":"3 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was sponsored by Servier (Tianjin) Pharmaceutical Co., Ltd. The Article Processing Charge was funded by Servier, France.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Zhou Jingmin, Xu Yamei, Zhang Yuhui, Ding Wenhui, Tang Baopeng, Qian Caizhen, Han Huiyuan, and Ge Junbo have received fees, research grants, or both, from Servier.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing Interests"}},{"value":"Informed consent was obtained from all study participants. This study was approved by the Ethics Committee of Zhongshan Hospital Fudan University (ref: B2016-118). The study was registered at the ISRCTN registry (registration number: 11703380).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\/Consent to participate"}},{"value":"Not applicable<i>.<\/i>","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors participated in the design of the study, interpretation of the data, and writing of the article. The statistical analysis was undertaken independently by ClinChoice Medical (TIANJIN) Co., Ltd. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have read and approved this version to be published.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}